These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 8589244

  • 1. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC, Schiller PW.
    Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
    Wilkes BC, Schiller PW.
    Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of sample pH on the conformational backbone dynamics of a pseudotripeptide (H-Tyr-Tic psi [CH2-NH]Phe-OH) incorporating a reduced peptide bond: an NMR investigation.
    Carpenter KA, Wilkes BC, Schiller PW.
    Biopolymers; 1995 Dec; 36(6):735-49. PubMed ID: 8555421
    [Abstract] [Full Text] [Related]

  • 6. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D, Mannekens E, Diem TN, Verheyden P, Jaspers H, Tóth G, Péter A, Kertész I, Török G, Chung NN, Schiller PW.
    J Med Chem; 1998 Dec 17; 41(26):5167-76. PubMed ID: 9857087
    [Abstract] [Full Text] [Related]

  • 7. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
    Chen H, Chung NN, Lemieux C, Zelent B, Vanderkooi JM, Gryczynski I, Wilkes BC, Schiller PW.
    Biopolymers; 2005 Dec 17; 80(2-3):325-31. PubMed ID: 15614807
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
    Bryant SD, Balboni G, Guerrini R, Salvadori S, Tomatis R, Lazarus LH.
    Biol Chem; 1997 Feb 17; 378(2):107-14. PubMed ID: 9088539
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
    Weltrowska G, Nguyen TM, Chung NN, Wilkes BC, Schiller PW.
    Bioorg Med Chem Lett; 2013 Sep 15; 23(18):5082-5. PubMed ID: 23932788
    [Abstract] [Full Text] [Related]

  • 14. A solid-phase synthetic strategy for labeled peptides: synthesis of a biotinylated derivative of the delta opioid receptor antagonist TIPP (Tyr-Tic-Phe-Phe-OH).
    Kumar V, Aldrich JV.
    Org Lett; 2003 Mar 06; 5(5):613-6. PubMed ID: 12605472
    [Abstract] [Full Text] [Related]

  • 15. Selective opioid dipeptides.
    Temussi PA, Salvadori S, Amodeo P, Bianchi C, Guerrini R, Tomatis R, Lazarus LH, Picone D, Tancredi T.
    Biochem Biophys Res Commun; 1994 Feb 15; 198(3):933-9. PubMed ID: 8117299
    [Abstract] [Full Text] [Related]

  • 16. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
    Schiller PW, Fundytus ME, Merovitz L, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Coderre TJ.
    J Med Chem; 1999 Sep 09; 42(18):3520-6. PubMed ID: 10479285
    [Abstract] [Full Text] [Related]

  • 17. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 18. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, Lazarus LH.
    J Med Chem; 1997 Sep 12; 40(19):3100-8. PubMed ID: 9301674
    [Abstract] [Full Text] [Related]

  • 19. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL, Pogozheva ID, Mosberg HI.
    Biopolymers; 1996 Feb 12; 38(2):221-34. PubMed ID: 8589255
    [Abstract] [Full Text] [Related]

  • 20. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.
    Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN, Lemieux C.
    J Med Chem; 1993 Oct 15; 36(21):3182-7. PubMed ID: 8230106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.